OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Type-1 cytokines regulate matrix metalloprotease-9 production and E-cadherin disruption to promote melanocyte loss in vitiligo
Nesrine Boukhedouni, Christina Martins, A.‐S. Darrigade, et al.
JCI Insight (2020)
Open Access | Times Cited: 54

Showing 1-25 of 54 citing articles:

Mechanisms of melanocyte death in vitiligo
Jianru Chen, Shuli Li, Chunying Li
Medicinal Research Reviews (2020) Vol. 41, Iss. 2, pp. 1138-1166
Open Access | Times Cited: 187

Anatomically distinct fibroblast subsets determine skin autoimmune patterns
Zijian Xu, Daoming Chen, Yucheng Hu, et al.
Nature (2021) Vol. 601, Iss. 7891, pp. 118-124
Closed Access | Times Cited: 159

Janus Kinase Inhibitors in the Treatment of Vitiligo: A Review
Qi Fei, Fang Liu, Ling Gao
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 115

Update on the pathogenesis of vitiligo
Helena Zenedin Marchioro, Caio César Silva de Castro, Vinicius M. Fava, et al.
Anais Brasileiros de Dermatologia (2022) Vol. 97, Iss. 4, pp. 478-490
Open Access | Times Cited: 83

The Role of Oxidative Stress in Vitiligo: An Update on Its Pathogenesis and Therapeutic Implications
Wei‐Ling Chang, Chi-Hsiang Ko
Cells (2023) Vol. 12, Iss. 6, pp. 936-936
Open Access | Times Cited: 57

Worldwide expert recommendations for the diagnosis and management of vitiligo: Position statement from the international Vitiligo Task Force—Part 2: Specific treatment recommendations
Julien Séneschal, Reinhart Speeckaert, Alain Taı̈eb, et al.
Journal of the European Academy of Dermatology and Venereology (2023) Vol. 37, Iss. 11, pp. 2185-2195
Open Access | Times Cited: 57

Combination of Baricitinib and Phototherapy in Adults With Active Vitiligo
Julien Séneschal, Mathilde Guyon, Ribal Merhi, et al.
JAMA Dermatology (2025)
Closed Access | Times Cited: 2

An update on Vitiligo pathogenesis
Julien Séneschal, Katia Boniface, Andrea D’Arino, et al.
Pigment Cell & Melanoma Research (2020) Vol. 34, Iss. 2, pp. 236-243
Open Access | Times Cited: 103

Clinical Features, Immunopathogenesis, and Therapeutic Strategies in Vitiligo
Yinghan Wang, Shuli Li, Chunying Li
Clinical Reviews in Allergy & Immunology (2021) Vol. 61, Iss. 3, pp. 299-323
Closed Access | Times Cited: 60

Characteristics and pathogenesis of Koebner phenomenon
Xiaolin Zhang, Lei Li, Ling Jiang, et al.
Experimental Dermatology (2022) Vol. 32, Iss. 4, pp. 310-323
Closed Access | Times Cited: 44

TNFα induces matrix metalloproteinase-9 expression in monocytic cells through ACSL1/JNK/ERK/NF-kB signaling pathways
Areej Al-Roub, Nadeem Akhter, Fatema Al‐Rashed, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 22

Pathogenesis of Alopecia Areata and Vitiligo: Commonalities and Differences
Hiroki L. Yamaguchi, Yuji Yamaguchi, Elena Peeva
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 8, pp. 4409-4409
Open Access | Times Cited: 12

Vitiligo, From Physiopathology to Emerging Treatments: A Review
Laure Migayron, Katia Boniface, Julien Séneschal
Dermatology and Therapy (2020) Vol. 10, Iss. 6, pp. 1185-1198
Open Access | Times Cited: 54

Vitiligo Skin T Cells Are Prone to Produce Type 1 and Type 2 Cytokines to Induce Melanocyte Dysfunction and Epidermal Inflammatory Response Through Jak Signaling
Christina Martins, Laure Migayron, Claire Drullion, et al.
Journal of Investigative Dermatology (2021) Vol. 142, Iss. 4, pp. 1194-1205.e7
Open Access | Times Cited: 45

Translational Research in Vitiligo
Erica L. Katz, John E. Harris
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 44

Current Concepts of Vitiligo Immunopathogenesis
Nika Hlača, Tina Žagar, Marija Kaštelan, et al.
Biomedicines (2022) Vol. 10, Iss. 7, pp. 1639-1639
Open Access | Times Cited: 34

Baricitinib is Effective in Treating Progressing Vitiligo in vivo and in vitro
Jie Dong, Xuan Huang, Li-Ping Ma, et al.
Dose-Response (2022) Vol. 20, Iss. 2
Open Access | Times Cited: 30

Melanocyte-keratinocyte cross-talk in vitiligo
Ahmed Ahmed Touni, Rohan Shivde, Harika Echuri, et al.
Frontiers in Medicine (2023) Vol. 10
Open Access | Times Cited: 17

JAK inhibitors for the treatment of vitiligo
Shintaro Inoue, Tamio Suzuki, Shigetoshi Sano, et al.
Journal of Dermatological Science (2024) Vol. 113, Iss. 3, pp. 86-92
Open Access | Times Cited: 7

Altered epidermal proliferation, differentiation, and lipid composition: Novel key elements in the vitiligo puzzle
Daniela Kovacs, Emanuela Bastonini, Stefania Briganti, et al.
Science Advances (2022) Vol. 8, Iss. 35
Open Access | Times Cited: 24

Role of Cytokines and Chemokines in Vitiligo and Their Therapeutic Implications
Marcelina Kądziela, Magdalena Kutwin, Paulina Karp, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 16, pp. 4919-4919
Open Access | Times Cited: 4

The Key of the Terminal Stage of Vitiligo: The Death Form of Melanocytes
Chen Zhang, Yuanyi Gao, Wei Yan, et al.
Dermatologic Therapy (2025) Vol. 2025, Iss. 1
Open Access

Recent clinical and mechanistic insights into vitiligo offer new treatment options for cell-specific autoimmunity
Khaled Ezzedine, Rim Tannous, T. Pearson, et al.
Journal of Clinical Investigation (2025) Vol. 135, Iss. 2
Closed Access

Role of E-cadherin in epithelial barrier dysfunction: implications for bacterial infection, inflammation, and disease pathogenesis
Panagiotis-Petros Lialios, Stella Alimperti
Frontiers in Cellular and Infection Microbiology (2025) Vol. 15
Open Access

Page 1 - Next Page

Scroll to top